Advertisement

Topics

Stiefel Laboratories, Inc., Barrier Therapeutics, Inc., Bengal Acquisition Inc., Mellon Investor Services LLC Company Profile

00:59 EST 25th November 2017 | BioPortfolio


News Articles [1643 Associated News Articles listed on BioPortfolio]

Catalysts developed at Carnegie Mellon efficiently and rapidly remove BPA from water

(Carnegie Mellon University) Carnegie Mellon University chemist Terrence J. Collins has developed an approach that quickly and cheaply removes more than 99 percent of bisphenol A (BPA) from water. B...

Summit Therapeutics plc: Summit Therapeutics to Participate in Upcoming Investor Conferences

Summit Therapeutics plc ('Summit', or the 'Company')SUMMIT THERAPEUTICS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCESOxford, UK, 22 November 2017- Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUM...

Brain research is underserved by statistics, says Carnegie Mellon's Rob Kass

(Carnegie Mellon University) The federal government launched the BRAIN Initiative in 2013 to ignite the development and application of new technologies needed for major advances toward understanding t...

New tool can help job searchers better position themselves in market

(Carnegie Mellon University) A novel method, developed by an economist at the Tepper School of Business at Carnegie Mellon University, has been created to evaluate a worker's skillset and determine it...

Concurrent with BMS acquisition, IFM Therapeutics spins off IFM Therapeutics LLC

Innate immunity-focused IFM Therapeutics is spinning off its non-oncology assets into the new company IFM Therapeutics LLC.

Funding round brings in about $7.1M for Mellon Medical

A round of funding pulled in approximately $7.1 million for Mellon Medical, a Dutch company that makes the Switch single-use  -More- 

Engineers Work to Make 3D Printed Human Heart a Reality

ArticleThe Regenerative Biomaterials and Therapeutics Group at Carnegie Mellon is working on new techniques for 3D bioprinting.Staff Author: 

Fuel economy standards cheaper, more beneficial than previously believed

(College of Engineering, Carnegie Mellon University) The regulations that set fuel-economy and greenhouse-gas emission goals for cars and trucks have lower costs and higher benefits than previous anal...

PubMed Articles [1494 Associated PubMed Articles listed on BioPortfolio]

A Reply to Stiefel et al. "Losing the 'Person' in Personalized Medicine".

Current Models of Investor State Dispute Settlement Are Bad for Health: The European Union Could Offer an Alternative Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?"

In this commentary, we endorse concerns about the health impact of the trans-pacific partnership (TPP), paying particular attention to its mechanisms for investor state dispute settlement. We then des...

An Intrathermocline Eddy and a tropical cyclone in the Bay of Bengal.

The Bay of Bengal, subjected to monsoonal forcing and tropical cyclones, displays a complex field of ocean eddies. On 5 December 2013 a sub-surface vortex or Intrathermocline Eddy (ITE) composed of wa...

Corneal Wound Repair After Rose Bengal and Green Light Crosslinking: Clinical and Histologic Study.

To evaluate corneal wound healing after treatment with a new collagen crosslinking protocol using rose bengal dye and green light (RGX).

Claudin-5 regulates blood-brain barrier permeability by modifying brain microvascular endothelial cell proliferation, migration, and adhesion to prevent lung cancer metastasis.

To investigate the roles of Claudin-5 (CLDN5) in regulating the permeability of the blood-brain barrier (BBB) during lung cancer brain metastasis.

Clinical Trials [975 Associated Clinical Trials listed on BioPortfolio]

The Acquisition of Blood and Skin Samples From Normal Volunteers to Support Research Activities on Dermatologic Diseases

Background: -This protocol is concerned with the acquisition of blood, skin, or mucosal samples from healthy volunteers or patients with selected skin diseases to support the basic scienc...

Virtual Task in Amyotrophic Lateral Sclerosis

Thirty individuals with ALS (18 men and 12 women, mean age 59 years, range 44-74 years), and 30 healthy controls matched for age and gender, participated. Individuals with ALS and from the...

DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery

To evaluate the safety and effectiveness of DuraGen Plus® Adhesion Barrier Matrix as an adhesion barrier in spinal surgery to reduce the extent of peridural fibrosis formation and radicul...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

VANOS Cream and Skin Barrier Function

The purpose of this study is to determine the effect of short-term therapy using "VANOS Cream," a super-potent topical steroid cream on skin barrier function in patients with atopic dermat...

Companies [2779 Associated Companies listed on BioPortfolio]

Stiefel Laboratories, Inc., Barrier Therapeutics, Inc., Bengal Acquisition Inc., Mellon Investor Services LLC

Stiefel Laboratories, Inc.

Stiefel Laboratories is enthusiastically committed to advancing dermatology and skin science around the world. The company's deeply-rooted dedication and drive for innovation along with its sole focus...

Stiefel, a GSK company

Stiefel, a GSK company, is committed to advancing dermatology and skin science around the world in order to help people better achieve healthier skin. Stiefel's dedication to innovation, along with i...

Barrier Therapeutics

BARRIER THERAPEUTICS is a pharmaceutical company focused on the discovery, development and commercialization of pharmaceutical products in the field of dermatology. Our goal is to develop a portfolio ...

Barrier Advisors Inc.

A nationally recognized financial and operational advisory firm with offices in Dallas, Texas and Stamford, Conn., Barrier Advisors provides special situations investment banking,...

More Information about "Stiefel Laboratories, Inc., Barrier Therapeutics, Inc., Bengal Acquisition Inc., Mellon Investor Services LLC" on BioPortfolio

We have published hundreds of Stiefel Laboratories, Inc., Barrier Therapeutics, Inc., Bengal Acquisition Inc., Mellon Investor Services LLC news stories on BioPortfolio along with dozens of Stiefel Laboratories, Inc., Barrier Therapeutics, Inc., Bengal Acquisition Inc., Mellon Investor Services LLC Clinical Trials and PubMed Articles about Stiefel Laboratories, Inc., Barrier Therapeutics, Inc., Bengal Acquisition Inc., Mellon Investor Services LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Stiefel Laboratories, Inc., Barrier Therapeutics, Inc., Bengal Acquisition Inc., Mellon Investor Services LLC Companies in our database. You can also find out about relevant Stiefel Laboratories, Inc., Barrier Therapeutics, Inc., Bengal Acquisition Inc., Mellon Investor Services LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record